Risk sharing agreements soar as market access risk increases
Pharmaceutical Technology
MARCH 17, 2023
In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”. Watt explained that for newer, first-in-class drugs these types of agreements can also give healthcare systems safety in their decisions to approve certain drugs. Click here to watch this webinar and access the presentation.
Let's personalize your content